Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-15-029230
Filing Date
2015-05-11
Accepted
2015-05-11 15:41:34
Documents
4
Effectiveness Date
2015-05-11

Document Format Files

Seq Description Document Type Size
1 FORM S-8 v410265_s8.htm S-8 87421
2 EXHIBIT 4.1 v410265_ex4-1.htm EX-4.1 152417
3 EXHIBIT 5.1 v410265_ex5-1.htm EX-5.1 7337
4 EXHIBIT 23.1 v410265_ex23-1.htm EX-23.1 2697
  Complete submission text file 0001144204-15-029230.txt   251181
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
PLASMATECH BIOPHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-204055 | Film No.: 15850484
SIC: 2834 Pharmaceutical Preparations